Kore Private Wealth LLC Biogen Inc. Transaction History

Kore Private Wealth LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $35,479 - $40,965	-134 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $3,621 - $4,795	-14 Reduced 9.46%	134 $35,000
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $10,216 - $12,959	38 Added 34.55%	148 $47,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $24,206 - $33,447	110 New	110 $33,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $23,902 - $26,347	-109 Closed	0 $0
Q4 2018 May 23, 2019	BUY	$278.5 - $352.75 $30,356 - $38,449	109 New	109 $33,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.